Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-08 2:08 pm Sale | 2021-10-12 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital Research Global Investors | 3,361,792 5.000% | -3,900,109 (-53.71%) | Filing History |
| 2021-09-10 12:06 pm Sale | 2021-09-10 | 13G | Applied Molecular Transport Inc. AMTI | Capital Research Global Investors | 1,708,437 4.400% | -2,313,243 (-57.52%) | Filing History |
| 2021-08-10 12:21 pm Sale | 2021-08-10 | 13G | Lamb Weston Holdings, Inc. LW | Capital Research Global Investors | 2,803,647 1.900% | -9,291,291 (-76.82%) | Filing History |
| 2021-08-10 12:21 pm Sale | 2021-08-10 | 13G | Diamondback Energy, Inc. FANG | Capital Research Global Investors | 11,109,260 6.100% | -8,227,745 (-42.55%) | Filing History |
| 2021-08-10 12:21 pm Sale | 2021-08-10 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital Research Global Investors | 3,842,491 4.800% | -4,181,639 (-52.11%) | Filing History |
| 2021-07-09 12:27 pm Purchase | 2021-07-09 | 13G | ACV Auctions Inc. ACVA | Capital Research Global Investors | 2,076,470 10.900% | 2,076,470 (New Position) | Filing History |
| 2021-07-09 12:27 pm Sale | 2021-07-09 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Capital Research Global Investors | 466,422 2.800% | -1,424,365 (-75.33%) | Filing History |
| 2021-06-10 11:46 am Purchase | 2021-06-10 | 13G | NICE Ltd. NICE | Capital Research Global Investors | 6,495,474 10.300% | 6,495,474 (New Position) | Filing History |
| 2021-06-10 11:46 am Sale | 2021-06-10 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,775,636 5.400% | -2,862,099 (-50.77%) | Filing History |
| 2021-06-10 11:46 am Purchase | 2021-06-10 | 13G | PAR Technology Corporation PAR | Capital Research Global Investors | 2,648,851 10.200% | 830,191 (+45.65%) | Filing History |
| 2021-05-10 1:41 pm Purchase | 2021-05-10 | 13G | Applied Molecular Transport Inc. AMTI | Capital Research Global Investors | 4,021,680 10.600% | 1,218,980 (+43.49%) | Filing History |
| 2021-04-09 5:38 pm Unchanged | 2021-04-09 | 13G | Olo Inc. OLO | Capital Research Global Investors | 3,420,000 16.500% | 0 (Unchanged) | Filing History |
| 2021-04-09 3:07 pm Purchase | 2021-04-09 | 13G | Olo Inc. OLO | Capital Research Global Investors | 3,420,000 16.500% | 3,420,000 (New Position) | Filing History |
| 2021-03-10 11:42 am Purchase | 2021-03-10 | 13G | Burlington Stores, Inc. BURL | Capital Research Global Investors | 6,626,338 10.000% | 187,933 (+2.92%) | Filing History |
| 2021-03-10 11:42 am Sale | 2021-03-10 | 13G | GW PHARMACEUTICALS PLC GWPH | Capital Research Global Investors | 16,701,517 4.500% | -28,132,995 (-62.75%) | Filing History |
| 2021-03-10 11:39 am Sale | 2021-03-10 | 13G | bluebird bio, Inc. BLUE | Capital Research Global Investors | 0 0.000% | -627,504 (Position Closed) | Filing History |